# The Safety and Efficacy of Carotid Body Modulation Therapy in Hypertensive Patients by External Ultrasonic Micro-bubble

Study · id `cardio:ct-nct06116357` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06116357](<https://clinicaltrials.gov/study/NCT06116357>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06116357

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT06116357. Allocation not applicable; no masking; primary purpose treatment. Start 2023-12-01 (anticipated); primary completion 2026-09-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT06116357, source copy `cardio:ctgov-nct06116357-2023-11-03`, retrieved 2026-10-26)
- Planned start: 2023-12-01 (anticipated) (ClinicalTrials.gov record NCT06116357, source copy `cardio:ctgov-nct06116357-2023-11-03`, retrieved 2026-10-26)
- Primary completion: 2026-09-01 (anticipated) (ClinicalTrials.gov record NCT06116357, source copy `cardio:ctgov-nct06116357-2023-11-03`, retrieved 2026-10-26)
- Completion: 2026-12-30 (anticipated) (ClinicalTrials.gov record NCT06116357, source copy `cardio:ctgov-nct06116357-2023-11-03`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06116357, source copy `cardio:ctgov-nct06116357-2023-11-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06116357-2023-11-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Safety and Efficacy of Carotid Body Modulation Therapy in Hypertensive Patients by External Ultrasonic Micro-bubble
- Condition: Primary Hypertension
- Intervention (Device): External Ultrasonic Micro-bubble
- Lead sponsor: Jing Huang
- Lead sponsor class: OTHER
- Collaborator: The Second Affiliated Hospital of Chongqing Medical University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as a collaborator: The Second Affiliated Hospital of Chongqing Medical University (`cardio:org-the-second-affiliated-hospital-of-chongqing-medical-739711`)

## Provenance

Content hash: defd3d02cebac89902feed329b9a73ab66eeddec9dd8e847d3258377f3bc5764
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
